Regulation of Trade in Drugs Act

[AI summary unavailable — showing source text] Regulation of Trade in Drugs Act - Finds that the dispensing of drugs and devices or the receipt of fiduciary incentives by medical practitioners in connection with the supplying of such products to patients except under certain limited circumstances is inconsistent with the interests of public health, denies consumers free access to an open market, and induces unfair trade practices. Makes it unlawful for a drug company to give or sell to a medical practitioner any legal or beneficial interest in the company or in the income thereof with the intent to induce such practitioner to prescribe the company's drugs to his patients. Makes such giving or selling of such interest without a public offering prima facie evidence of such intent or purpose. Makes it unlawful for a medical practitioner to acquire or own a legal or beneficial interest in any drug company unless such acquisition is solely for investment. Makes a general public offering of such acquisition prima facie evidence that the acquisition is solely for investment. Makes it unlawful for a medical practitioner to solicit or knowingly receive from a drug company, or for a drug company to pay or promise to pay to a medical prac…